References |
1. Moro O, Wakita K, Ohnuma M, Denda S, Lerner EA, Tajima M. (1999)
Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase-activating peptide type 1 receptor-specific antagonist. J Biol Chem, 274 (33): 23103-10. [PMID:10438479] |